Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zogenix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Zogenix Inc, Medical Devices Deals, 2012 to YTD 2018 10
Zogenix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zogenix Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 12
Zogenix Amends Co-Marketing Agreement With Battelle Memorial Institute For DosePro 13
Licensing Agreements 14
Zogenix Enters Into Licensing Agreement With Altus Formulation For Zohydro ER 14
Zogenix International Amends Licensing Agreement with University of Antwerp and University of Leuven 15
Equity Offering 16
Zogenix Prices Public Offering of Shares for USD312 Million 16
Zogenix Raises USD289 Million in Public Offering of Shares 18
Zogenix Raises USD98.3 Million in Public Offering of Shares 20
Zogenix Raised USD10.8 Million in Public Offering Of Shares 22
Zogenix Completes Public Offering Of Shares For US$69 Million 23
Zogenix Completes Public Offering Of Units For US$70 Million 25
Asset Transactions 26
Pernix Acquires Zohydro ER Business from Zogenix 26
Endo International Completes Acquisition of Sumavel DosePro Migraine Therapy Business from Zogenix 28
Acquisition 29
Zogenix Acquires Brabant Pharma for USD130 Million 29
Zogenix Inc – Key Competitors 30
Zogenix Inc – Key Employees 31
Zogenix Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 06, 2018: Zogenix provides corporate update and reports second quarter financial results 33
May 09, 2018: Zogenix Provides Corporate Update and Reports First Quarter Financial Results 35
Mar 06, 2018: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results 37
Nov 07, 2017: Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Results 39
Aug 08, 2017: Zogenix Provides Corporate Update and Reports Second Quarter 2017 Financial Results 41
May 04, 2017: Zogenix Reports First Quarter 2017 Financial Results 43
Mar 09, 2017: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 44
Corporate Communications 46
Jul 02, 2018: Zogenix Appoints Ashish Sagrolikar As New Global Chief Commercial Officer 46
Jan 05, 2017: Zogenix Announces CFO Transition 47
Product News 48
05/22/2017: Zogenix Announces Presentation of ZX008 Mechanism of Action Data at Annual Meeting of Society of Biological Psychiatry 48
02/06/2018: Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome 49
Product Approvals 50
Jun 22, 2017: Zogenix Receives Orphan Drug Designation from FDA for ZX008 in Treatment of Lennox Gastaut Syndrome 50
Mar 01, 2017: Zogenix Receives Orphan Drug Designation in the European Union for ZX008 in Lennox Gastaut Syndrome 51
Clinical Trials 52
Jan 31, 2018: Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome 52
Dec 04, 2017: Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase III Clinical Trial of ZX008 in Dravet Syndrome 53
Nov 29, 2017: Zogenix Announces Initiation of Phase 3 Trial for ZX008 in Lennox-Gastaut Syndrome 55
Nov 28, 2017: Zogenix To Host Call with Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4 56
Nov 21, 2017: New Data from Zogenix’s Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting 57
Oct 16, 2017: Zogenix Provides Update on ZX008 59
Sep 29, 2017: Zogenix Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome 60
May 04, 2017: Zogenix Provides Update On Phase 3 Study Of ZX008 61
Apr 27, 2017: Zogenix Completes Enrollment in First ZX008 Phase 3 Clinical Trial in Dravet Syndrome 62
Feb 13, 2017: Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
Zogenix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zogenix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zogenix Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Zogenix Inc, Medical Devices Deals, 2012 to YTD 2018 10
Zogenix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 12
Zogenix Amends Co-Marketing Agreement With Battelle Memorial Institute For DosePro 13
Zogenix Enters Into Licensing Agreement With Altus Formulation For Zohydro ER 14
Zogenix International Amends Licensing Agreement with University of Antwerp and University of Leuven 15
Zogenix Prices Public Offering of Shares for USD312 Million 16
Zogenix Raises USD289 Million in Public Offering of Shares 18
Zogenix Raises USD98.3 Million in Public Offering of Shares 20
Zogenix Raised USD10.8 Million in Public Offering Of Shares 22
Zogenix Completes Public Offering Of Shares For US$69 Million 23
Zogenix Completes Public Offering Of Units For US$70 Million 25
Pernix Acquires Zohydro ER Business from Zogenix 26
Endo International Completes Acquisition of Sumavel DosePro Migraine Therapy Business from Zogenix 28
Zogenix Acquires Brabant Pharma for USD130 Million 29
Zogenix Inc, Key Competitors 30
Zogenix Inc, Key Employees 31
Zogenix Inc, Other Locations 32
Zogenix Inc, Subsidiaries 32
List of Figures
Zogenix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Zogenix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Zogenix Inc, Medical Devices Deals, 2012 to YTD 2018 10